Kansas City Cardiomyopathy Questionnaire clinical summary score

1. Semaglutide or tirzepatide improves Kansas City Cardiomyopathy Questionnaire clinical summary score in humans (+7.39 points, 95% CI 5.43-9.35).

   Human trialin patients with heart failure with preserved ejection fraction and obesity

   The effects of tirzepatide and semaglutide on clinical and metabolic outcomes in patients with heart failure with preserved ejection fraction and obesity: a systematic review and meta-analysis · Nutrition, metabolism, and cardiovascular diseases : NMCD · 8 Sep 2026

Semaglutide or tirzepatide →